-
France wants extra fee on small packages coming from outside EU
Concerns grow over sales from e-commerce giants such as Temu and Shein
-
British woman’s murder in Dordogne: ‘personal grudge’ motive investigated
Police are reported to be concentrating on people likely to wish direct ill of Karen Carter who was fatally stabbed on April 29
-
Video: Hailstorm pelts Paris and Lyon ending early heatwave
Dramatic scenes as hail the size of golf balls fell in some areas on Saturday
Why might I be asked to wear a mask on French public transport?
Town halls and pharmacies are distributing face masks as part of the ‘Masque solidaire’ campaign

People are being urged to wear face masks in confined public spaces as part of a new campaign to protect France’s 300,000 vulnerable and immunocompromised people from Covid-19 and other respiratory infections.
Patients who have received organ transplants or cancer treatment, or have HIV, are among those at risk of hospitalisation and even death from infections.
In the last four years, Covid has killed one in 20 dialysis patients in France.
Read more: Flu, Covid, bronchiolitis: latest update on viruses in France
Only 50% of people would wear a mask if they had symptoms
The campaign, organised by three associations representing the immunocompromised, is called Masque solidaire (Solidarity mask).
On January 6 alone, 50,000 face masks were handed out by volunteers at the Place de la République in Paris.
Overall, 100 town halls and 400 pharmacies have so far participated in the campaign by distributing masks and displaying messages on buses, metros and in the streets, as well as online and on social media.
Just 15% of people in the country now wear a face mask when travelling on public transport, and only half plan to wear a mask if they start displaying symptoms, according to the most recent survey by Santé publique France.
Related articles
Covid vaccine disturbs menstruation for some women, finds French study
Doctors concerned over low take-up of Covid and flu vaccines in France
What are characteristics of Covid variant JN1, now dominant in France?